Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cyclacel secures $60 million equity financing facility
Under the terms of the agreement, Cyclacel will determine the exact timing and amount of any committed equity financing facility (CEFF) financings, subject to certain conditions. Kingsbridge is
Under the terms of the agreement, Cyclacel will determine the exact timing and amount of any committed equity financing facility (CEFF) financings, subject to certain conditions. Kingsbridge is
According to the terms of the agreement, Anesiva is entitled to an undisclosed up-front payment and a fixed transfer price. Medical Futures will be responsible for all the
The proceeds from the loan will be used in part to finance the analysis of unblinded data on BiovaxID, an active immunotherapeutic in a pivotal Phase III study
Under the terms of the agreement, the parties intend to make the new Potelligent CHOK1SV cell line available for licensing and it will be offered as part of
Fovea plans to use the proceeds from this financing to advance its clinical and preclinical pipeline and further develop its technology platform. In 2008, Fovea expects to advance
According to the signed agreement between the two firms, the first phase of the partnership will commence immediately, and will include the commercialization and exporting of existing Organogenesis
An animal model of experimental autoimmune encephalomyelistis (EAE) designed to replicate multiple sclerosis (MS), was used to study the efficacy of Symadex in both acute and chronic phases
The purchase price for each share of common stock is $1.90 and the warrants are exercisable from the date of grant until the fifth anniversary of such date
In the current trial, approximately 375 patients will be enrolled to receive either Allovectin-7 alone or the current standard chemotherapy (dacarbazine or temozolomide) alone. In all, 67% of
Panzem is a small molecule metabolite of 17beta-estradiol which, in its purified form, has antiproliferative, apoptotic and antiangiogenic activity. In three distinct preclinical treatment models, oral administration of